BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19633959)

  • 1. Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians.
    Kantrowitz JT; Nolan KA; Sen S; Simen AA; Lachman HM; Bowers MB
    Psychiatr Q; 2009 Dec; 80(4):213-8. PubMed ID: 19633959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
    Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
    Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis, COMT and psychotic experiences.
    Zammit S; Owen MJ; Evans J; Heron J; Lewis G
    Br J Psychiatry; 2011 Nov; 199(5):380-5. PubMed ID: 21947654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
    van Winkel R; Henquet C; Rosa A; Papiol S; Fananás L; De Hert M; Peuskens J; van Os J; Myin-Germeys I
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):10-7. PubMed ID: 17525974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
    Caspi A; Moffitt TE; Cannon M; McClay J; Murray R; Harrington H; Taylor A; Arseneault L; Williams B; Braithwaite A; Poulton R; Craig IW
    Biol Psychiatry; 2005 May; 57(10):1117-27. PubMed ID: 15866551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
    Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence.
    Baransel Isir AB; Oguzkan S; Nacak M; Gorucu S; Dulger HE; Arslan A
    Am J Forensic Med Pathol; 2008 Dec; 29(4):320-2. PubMed ID: 19259017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
    Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
    Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
    Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.
    Batalla A; Soriano-Mas C; López-Solà M; Torrens M; Crippa JA; Bhattacharyya S; Blanco-Hinojo L; Fagundo AB; Harrison BJ; Nogué S; de la Torre R; Farré M; Pujol J; Martín-Santos R
    Addict Biol; 2014 Jul; 19(4):722-32. PubMed ID: 23311613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the
    Lodhi RJ; Wang Y; Rossolatos D; MacIntyre G; Bowker A; Crocker C; Ren H; Dimitrijevic A; Bugbee DA; Loverock A; Majeau B; Sivapalan S; Newton VM; Tibbo P; Purdon SE; Aitchison KJ
    Brain Behav; 2017 Nov; 7(11):e00850. PubMed ID: 29201551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia.
    Ermis A; Erkiran M; Dasdemir S; Turkcan AS; Ceylan ME; Bireller ES; Cakmakoglu B
    In Vivo; 2015; 29(1):129-32. PubMed ID: 25600541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms.
    Carvalho C; Vieira-Coelho MA
    Pharmacol Res; 2022 Jul; 181():106258. PubMed ID: 35588917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.
    Collip D; van Winkel R; Peerbooms O; Lataster T; Thewissen V; Lardinois M; Drukker M; Rutten BP; Van Os J; Myin-Germeys I
    CNS Neurosci Ther; 2011 Dec; 17(6):612-9. PubMed ID: 21073668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
    Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
    J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
    Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.
    Alemany S; Arias B; Fatjó-Vilas M; Villa H; Moya J; Ibáñez MI; Ortet G; Gastó C; Fañanás L
    Acta Psychiatr Scand; 2014 Jan; 129(1):54-62. PubMed ID: 23445265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interplay between cannabis and psychosis.
    Henquet C; Di Forti M; Morrison P; Kuepper R; Murray RM
    Schizophr Bull; 2008 Nov; 34(6):1111-21. PubMed ID: 18723841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.